Simon Jupp

Simon is a senior associate in the IP & Media group, specialising in all aspects of soft IP and advertising. He provides support to his clients on a wide range of contentious and non-contentious issues, including advisory, litigation, compliance, commercial, transactions and corporate support. His work includes advising on trade mark and design protection and portfolio management.

Simon has acted for clients across a range of dispute forums, including the High Court, Court of Appeal and Intellectual Property Enterprise Court. He also regularly represents clients in registry proceedings before the UK and EU Intellectual Property Offices and the Appointed Person.

Afficher le CV complet Masquer le CV complet

Carrière

Since 2020	Senior associate, Taylor Wessing
2017 - 2020	Associate, Taylor Wessing
2015 - 2017	Solicitor, Shoosmiths

2014 - 2015	In house legal counsel, Volkswagen Group UK
2013 - 2015	Trainee Solicitor, Shoosmiths

Voir plus Moins

Formation

2015	Admitted as a lawyer, England & Wales
2013	Legal Practice Course, BBP Law School London
2012	Graduate Diploma in Law, BBP Law School London

2011

BA Hons, Economics & Philosophy, University of Nottingham

Voir plus Moins

Publications

Featured commenting on research from the Uni of Exeter on whether copyright can be applied to the walks of catwalk models in The Times
Quoted on the topic of copyright in white noise, World Intellectual Property Review, 2018
Quoted discussing the implications of blockchain technology for IP, The Times, 2018
Has time run out for the Anne Frank Fonds?, Intellectual Property Magazine, February 2016
Google and the right to be forgotten, Lawcareers.net, February 2015

Groupes & Associations

IPSoc

AIPPI

Langues étrangères

English

Expertise

Secteurs Technologie, Médias et Communications (TMC)Droit de la consommation Mode et luxe Publicité et marketing

Experience

Glenmark Pharma on the sale of its portfolio of CNS products in Poland to Neuraxpharm	Glenmark Pharma on its divestment of its CNS business in Poland including its portfolio of generics and branded generics products and the transfer of its commercial team in Poland to private equity backed Neuraxpharm, a specialty pharmaceutical company focused on the treatment of CNS disorders.
Apotex's EUR74m sale of subsidiaries to Aurobindo	Apotex on the sale of six European subsidiaries in Belgium, Poland, the Netherlands, Czech Republic and Spain, to Aurobindo for EUR74 million. This highly complex transaction involved the share transfer of subsidiaries in multiple jurisdictions being co-ordinated and managed by our UK team. We simultaneously advised on a multitude of business separation, ongoing product supply agreements and IP licences for the European business to continue operating after being removed from the Apotex group.
A global IT and networking company	A global IT and networking company on High Court litigation involving the sale of grey and counterfeit products.

A fashion retailer	A fashion retailer on High Court/Court of Appeal IP and breach of settlement agreement litigation.
An insurance group	An insurance group on the appointment of media buying agency.
An FMCG company	An FMCG company on providing IP advice on the divestment of UK business.

Voir plus Moins

Prix et distinctions

Legal 500 UK 2019	Recommended lawyer - Brand management
Legal 500 UK 2020	Rising star - TMT (technology, media and telecoms): Brand management
Managing Intellectual Property - IP Stars 2019	Rising star